Generic Name: lanreotide (lan REE oh tide)
Brand Name: Somatuline Depot
What is lanreotide?
Lanreotide is used in adults to treat:
acromegaly that cannot be treated with surgery or radiation;
carcinoid syndrome; or
a certain type of pancreatic or digestive tract tumor that may spread to other parts of the body.
Lanreotide is sometimes given after other treatments have failed.
Lanreotide may also be used for purposes not listed in this medication guide.
Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.
Before taking this medicine
You should not use lanreotide if you are allergic to it.
Tell your doctor if you have ever had:
diabetes (your diabetes medicine may need to be adjusted);
liver or kidney disease;
heart disease; or
a thyroid disorder.
It is not known whether lanreotide will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
This medicine may affect fertility (your ability to have children) in women.
You should not breast-feed while using lanreotide and for at least 6 months after your last dose.
How is lanreotide given?
Lanreotide is injected under the skin.
A healthcare provider will give you this injection.
Lanreotide is usually given once every 4 weeks. Your doctor may occasionally change how often you receive injections.
Call your doctor if your symptoms do not improve, or if they get worse.
Your blood sugar may need to be checked often, and you may need other blood tests at your doctor's office.
What happens if I miss a dose?
Call your doctor for instructions if you miss an appointment for your lanreotide injection.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while using lanreotide?
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
Lanreotide side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
chest pain, slow heartbeats;
shortness of breath;
a light-headed feeling, like you might pass out;
confusion, memory problems;
feeling very weak or tired;
a light-headed feeling, like you might pass out;
high blood sugar--increased thirst, increased urination, dry mouth, fruity breath odor;
signs of a gallbladder problem--sudden severe pain in your upper stomach spreading to your back or shoulder (may occur after meals or at night), nausea, fever, chills, yellowing of the skin or eyes.
Common side effects may include:
headache, pounding in your neck or ears;
muscle or joint pain;
headache, dizziness; or
pain, itching, or a hard lump where the medicine was injected.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Lanreotide dosing information
Usual Adult Dose for Acromegaly:
Initial dose: 90 mg, by deep subcutaneous injection, every 4 weeks for 3 months
-The goal of treatment is to reduce growth hormone (GH) and insulin-like growth factor (IGF-1) levels to normal.
-Adjust dose after initial 3 months.
-No dose adjustment is required for elderly patients.
Use: Long-term treatment of acromegalic patients who have had an inadequate response to surgery and/or radiotherapy, or for whom surgery and/or radiotherapy is not an option.
Usual Adult Dose for Neuroendocrine Carcinoma:
120 mg, by deep subcutaneous injection, every 4 weeks
Comments: No dose adjustment is required for elderly patients.
Use: Treatment of patients with unresectable, well or moderately-differentiated, locally advanced, or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) to improve progression-free survival.
Usual Adult Dose for Carcinoid Syndrome:
120 mg by deep subcutaneous injection every 4 weeks
Comments: If patients are already being treated for GEP-NETs, do not administer an additional dose for the treatment of carcinoid syndrome.
Use: For the treatment of carcinoid syndrome; when used, it reduces the frequency of short-acting somatostatin analog rescue therapy.
What other drugs will affect lanreotide?
When you start or stop taking lanreotide, your doctor may need to adjust the doses of any other medicines you take on a regular basis.
Tell your doctor about all your other medicines, especially:
insulin or oral diabetes medicine; or
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2018 Cerner Multum, Inc. Version: 6.01.
More about lanreotide
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- 1 Review
- Drug class: somatostatin and somatostatin analogs
Other brands: Somatuline Depot